Real-time Estimate Cboe Europe 12:00:02 19/07/2024 BST 5-day change 1st Jan Change
204.5 SEK -1.35% Intraday chart for Getinge AB +6.64% -9.01%
LockThis Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
Transcript : Getinge AB, Q2 2024 Earnings Call, Jul 18, 2024
Medical gear maker Getinge beats Q2 core profit expectations RE
Getinge AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders DJ
Getinge Shares Sink After It Limits Sales of Heart Devices DJ
Getinge Seeks Acquisitions CI
Transcript : Getinge AB - Analyst/Investor Day
Getinge limits sale of heart devices in the US after FDA warning RE
Getinge to Limit Some U.S. Cardiovascular-Device Sales After FDA Letter DJ
Getinge Shares Sink After FDA Warns on Heart Devices DJ
Europe's STOXX 600 hits record high on earnings, rate cut optimism RE
US FDA advises healthcare facilities to switch from Getinge's heart devices RE
US FDA recommends healthcare providers switch from Getinge's heart devices RE
Soltech Fires Up New Solar Park in Sweden MT
GETINGE : Q1 24: Investors look beyond the top-line miss Alphavalue
Nordic Stocks Closed Up Monday; Getinge Series B Climbed Highest DJ
Getinge AB Declares A Dividend, Payable on 29 April 2024 CI
Transcript : Getinge AB, Q1 2024 Earnings Call, Apr 22, 2024
Medical gear maker Getinge's Q1 core profit beats expectations RE
Getinge AB Reaffirms Sales Guidance for the Year 2024 CI
Getinge AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Getinge’s Covered Stent System Gets EU Medical Device Regulation Certification MT
GETINGE : EPS cut (2023: +3.1%, 2024: -10.5%) Alphavalue
Getinge AB Announces Barbro Fridén Declines Re-Election from the Board CI
Getinge AB Proposes Dividend, Payable on April 29, 2024 CI
Chart Getinge AB
More charts
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.451.9%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (34.5%); - contamination prevention equipment (13.6%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications. Net sales are distributed geographically as follows: Sweden (2%), Europe/Middle East/Africa (34.9%), the United States (36.8%), Americas (4.5%) and Asia/Pacific (21.8%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
207.3 SEK
Average target price
226.8 SEK
Spread / Average Target